Global ENT and Bronchoscopy Devices Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2028
“Global ENT and Bronchoscopy Devices Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028” is a recent report generated by MarketResearch.biz. The global ENT and bronchoscopy devices market report has been segmented on the basis of product, end user, and region.
Global ENT and Bronchoscopy Devices Market: Overview
ENT devices are used to rectify the smelling disorders, hearing disorders, as well as problems related to speaking or snoring. Bronchoscopy devices is an invasive procedure for visualization of the upper and lower respiratory tract for the diagnosis and management of a spectrum of inflammatory, infectious, and malignant diseases of the airway and lungs in humans. There are some types of bronchoscopes devices that can be steam sterilized that requires low temperatures for disinfection or sterilization.
Global ENT and Bronchoscopy Devices Market: Dynamics
Rising incidences of hearing and nasal disorders are key factors expected to drive the revenue growth of the target market over the forecast years. In addition, increasing geriatric population, growing patient’s preferences for minimally invasive procedures, increasing health care expenditure, are some of the factors boosting the demand for the ENT and bronchoscopy devices worldwide. Furthermore, education and rising awareness about health and wellbeing among the individuals is playing a critical role in increasing the demand for various hearing aids and diagnostic services.
However, high cost of ENT and bronchoscopy devices as well as lack of skilled professional especially in developing and under developing regions are the factor expected to hamper the growth of the target market to a certain extent.
Global ENT and Bronchoscopy Devices Market: Segment Analysis
On the basis of product segment, hearing care devices is expected to register largest market share owing to rising incidences of hear loss worldwide. On the basis of end user segment, hospitals & clinics segment is expected to witnessed highest revenue share. This is primarily to, increasing usage of these devices due to increasing incidences of chronic diseases.
Global ENT and Bronchoscopy Devices Market: Trends
The major manufacturers are adopting broadening marketing strategy and strengthen their marketing channels as well as increasing their products outreach to various hospitals, clinics and ambulatory centers. In addition, major players are focuses on receiving FDA approvals for their products. The aforementioned are some key trends witnessed in the target market.
For instance, In March 2018, Auris Health Inc., which is a US-based company received FDA-cleared monarch platform for robotic bronchoscopy. The monarch platform integrates the technological advancements in robotics, software, data science, and endoscope innovation, with an objective to improving patient outcomes, enhancing physician capabilities, and lowering costs to the healthcare system.
In March 2018, Intersect ENT Inc., which is a US-based company dedicated for patients with ear, nose, and throat conditions, launched SINUVA – an implant, a new approach to treating nasal polyp disease in adult patients.
Global ENT and Bronchoscopy Devices Market: Regional Analysis
In 2018, the markets in North America is anticipated to account for largest revenue share in the target market. This is primarily attributed to rising incidences of ear and throat related diseases as well as higher healthcare expenditure in countries in the region. The market in Asia Pacific is expected to gain highest growth rate, due to expansion of distribution network by major players and higher healthcare expenditure of general population in countries such as China and India in the Asia Pacific region.
Global ENT and Bronchoscopy Devices Market Segmentation:
Segmentation by product:
- Surgical ENT & Bronchoscopy Devices
- Hearing Care Devices
Segmentation by end user:
- Hospitals & Clinics
- Home Use
- Ambulatory Surgical Centers (ASCs)
Segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Estimated Year 2020 Actual Year 2021 Forecast Period 2021–2030 Revenue in US$
- Cochlear Limited
- Entellus Medical, Inc.
- Gn Store Nord A/S
- Hoya Corporation (Pentax Medical)
- Johnson & Johnson
- Karl Storz Gmbh & Co. Kg
- Medtronic Plc
- Olympus Corporation
- Sivantos Pte. Ltd.
- Smith & Nephew Plc.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!